Found: 40
Select item for more details and to access through your institution.
Solid Components in the Mediastinal Window of Computed Tomography Define a Distinct Subtype of Subsolid Nodules in Clinical Stage I Lung Cancers.
- Published in:
- Clinical Lung Cancer, 2021, v. 22, n. 4, p. 324, doi. 10.1016/j.cllc.2021.02.015
- By:
- Publication type:
- Article
Table of Contents.
- Published in:
- Clinical Lung Cancer, 2021, v. 22, n. 4, p. N.PAG, doi. 10.1016/S1525-7304(21)00154-6
- Publication type:
- Article
Editorial Board.
- Published in:
- Clinical Lung Cancer, 2021, v. 22, n. 4, p. A1, doi. 10.1016/S1525-7304(21)00153-4
- Publication type:
- Article
Patient-Reported Outcomes with Durvalumab With or Without Tremelimumab Versus Standard Chemotherapy as First-Line Treatment of Metastatic Non–Small-Cell Lung Cancer (MYSTIC).
- Published in:
- Clinical Lung Cancer, 2021, v. 22, n. 4, p. 301, doi. 10.1016/j.cllc.2021.02.010
- By:
- Publication type:
- Article
A Dose-finding Study Followed by a Phase II Randomized, Placebo-controlled Trial of Chemoradiotherapy With or Without Veliparib in Stage III Non–small-cell Lung Cancer: SWOG 1206 (8811).
- Published in:
- Clinical Lung Cancer, 2021, v. 22, n. 4, p. 313, doi. 10.1016/j.cllc.2021.02.009
- By:
- Publication type:
- Article
A Phase II Study to Assess the Efficacy of Osimertinib in Patients With EGFR Mutation-positive NSCLC Who Developed Isolated CNS Progression (T790M-negative or Unknown) During First- or Second-generation EGFR-TKI or Systemic Disease Progression (T790M-negative) After Treatment With First- or Second-generation EGFR-TKI and Platinum-based Chemotherapy (WJOG12819L)
- Published in:
- Clinical Lung Cancer, 2021, v. 22, n. 4, p. 376, doi. 10.1016/j.cllc.2020.12.009
- By:
- Publication type:
- Article
PTEN Loss as a Predictor of Tumor Heterogeneity and Poor Prognosis in Patients With EGFR-mutant Advanced Non–small-cell Lung Cancer Receiving Tyrosine Kinase Inhibitors.
- Published in:
- Clinical Lung Cancer, 2021, v. 22, n. 4, p. 351, doi. 10.1016/j.cllc.2020.12.008
- By:
- Publication type:
- Article
Prospective Validation of the Italian Alliance Against Cancer Lung Panel in Patients With Advanced Non–Small-Cell Lung Cancer.
- Published in:
- Clinical Lung Cancer, 2021, v. 22, n. 4, p. e637, doi. 10.1016/j.cllc.2020.12.007
- By:
- Publication type:
- Article
Characteristics and Outcomes of Lung Cancer Screening Among Individuals With or Without Cancer History.
- Published in:
- Clinical Lung Cancer, 2021, v. 22, n. 4, p. e629, doi. 10.1016/j.cllc.2020.12.006
- By:
- Publication type:
- Article
Ninety-Day Mortality: Redefining the Perioperative Period After Lung Resection.
- Published in:
- Clinical Lung Cancer, 2021, v. 22, n. 4, p. e642, doi. 10.1016/j.cllc.2020.12.011
- By:
- Publication type:
- Article
Second-line Afatinib or Chemotherapy Following Immunochemotherapy for the Treatment of Metastatic, Squamous Cell Carcinoma of the Lung: Real-world Effectiveness and Safety From a Multisite Retrospective Chart Review in the USA.
- Published in:
- Clinical Lung Cancer, 2021, v. 22, n. 4, p. 292, doi. 10.1016/j.cllc.2021.02.006
- By:
- Publication type:
- Article
Activity and Immune Correlates of Programmed Death-1 Blockade Therapy in Patients With Advanced Large Cell Neuroendocrine Carcinoma.
- Published in:
- Clinical Lung Cancer, 2021, v. 22, n. 4, p. 282, doi. 10.1016/j.cllc.2021.02.003
- By:
- Publication type:
- Article
Real World Characterization of Advanced Non–Small Cell Lung Cancer in Never Smokers by Actionable Mutation Status.
- Published in:
- Clinical Lung Cancer, 2021, v. 22, n. 4, p. 260, doi. 10.1016/j.cllc.2021.01.013
- By:
- Publication type:
- Article
A Prospective Trial Evaluating the Safety and Systemic Response From the Concurrent Use of Radiation Therapy with Checkpoint Inhibitor Immunotherapy in Metastatic Non–Small Cell Lung Cancer.
- Published in:
- Clinical Lung Cancer, 2021, v. 22, n. 4, p. 268, doi. 10.1016/j.cllc.2021.01.012
- By:
- Publication type:
- Article
Subtypes of EGFR- and HER2-Mutant Metastatic NSCLC Influence Response to Immune Checkpoint Inhibitors.
- Published in:
- Clinical Lung Cancer, 2021, v. 22, n. 4, p. 253, doi. 10.1016/j.cllc.2020.12.015
- By:
- Publication type:
- Article
Association of Immune-Related Adverse Events and Efficacy Outcomes With Consolidation Pembrolizumab After Chemoradiation in Patients With Inoperable Stage III Non–Small-Cell Lung Cancer.
- Published in:
- Clinical Lung Cancer, 2021, v. 22, n. 4, p. 274, doi. 10.1016/j.cllc.2020.12.014
- By:
- Publication type:
- Article
Treatment at Integrated Centers Might Bridge the Academic-Community Survival Gap in Patients With Metastatic Non-Small Cell Carcinoma of the Lung.
- Published in:
- Clinical Lung Cancer, 2021, v. 22, n. 4, p. e646, doi. 10.1016/j.cllc.2020.12.013
- By:
- Publication type:
- Article
Extended Sleeve Lobectomy is an Alternative for Centrally Located Lung Cancer With Superior Short- and Long-term Outcomes.
- Published in:
- Clinical Lung Cancer, 2021, v. 22, n. 4, p. e621, doi. 10.1016/j.cllc.2020.12.002
- By:
- Publication type:
- Article
Clinician Variation in Ordering and Completion of Low-Dose Computed Tomography for Lung Cancer Screening in a Safety-Net Medical System.
- Published in:
- Clinical Lung Cancer, 2021, v. 22, n. 4, p. e612, doi. 10.1016/j.cllc.2020.12.001
- By:
- Publication type:
- Article
Treatment of Non–Small-Cell Lung Cancer Based on Circulating Cell-Free DNA and Impact of Variation Allele Frequency.
- Published in:
- Clinical Lung Cancer, 2021, v. 22, n. 4, p. e519, doi. 10.1016/j.cllc.2020.11.007
- By:
- Publication type:
- Article
Decreased Overall Survival in HIV-associated Non–small-cell Lung Cancer.
- Published in:
- Clinical Lung Cancer, 2021, v. 22, n. 4, p. e498, doi. 10.1016/j.cllc.2020.11.006
- By:
- Publication type:
- Article
Surgical Prognosis of Synchronous Multiple Primary Lung Cancer: Systematic Review and Meta-Analysis.
- Published in:
- Clinical Lung Cancer, 2021, v. 22, n. 4, p. 341, doi. 10.1016/j.cllc.2020.10.022
- By:
- Publication type:
- Article
Prognostic Value of KRAS Mutation Subtypes and PD-L1 Expression in Patients With Lung Adenocarcinoma.
- Published in:
- Clinical Lung Cancer, 2021, v. 22, n. 4, p. e506, doi. 10.1016/j.cllc.2020.07.004
- By:
- Publication type:
- Article
Trabectedin in Malignant Pleural Mesothelioma: Results From the Multicentre, Single Arm, Phase II ATREUS Study.
- Published in:
- Clinical Lung Cancer, 2021, v. 22, n. 4, p. 361, doi. 10.1016/j.cllc.2020.06.028
- By:
- Publication type:
- Article
Survival Trends of Metastatic Lung Cancer in California by Age at Diagnosis, Gender, Race/Ethnicity, and Histology, 1990-2014.
- Published in:
- Clinical Lung Cancer, 2021, v. 22, n. 4, p. e602, doi. 10.1016/j.cllc.2020.11.005
- By:
- Publication type:
- Article
Feasibility of Performing Transvascular Endobronchial Ultrasound-Guided Transbronchial Needle Aspiration.
- Published in:
- Clinical Lung Cancer, 2021, v. 22, n. 4, p. e595, doi. 10.1016/j.cllc.2020.10.020
- By:
- Publication type:
- Article
Prognostic Significance of Lymph Node Count Removed at Sublobar Resection in Pathologic Stage IA Non–Small-cell Lung Cancer: A Population-Based Analysis.
- Published in:
- Clinical Lung Cancer, 2021, v. 22, n. 4, p. e563, doi. 10.1016/j.cllc.2020.09.015
- By:
- Publication type:
- Article
Osimertinib Maintenance After Definitive Chemoradiation in Patients With Unresectable EGFR Mutation Positive Stage III Non–small-cell Lung Cancer: LAURA Trial in Progress.
- Published in:
- Clinical Lung Cancer, 2021, v. 22, n. 4, p. 371, doi. 10.1016/j.cllc.2020.11.004
- By:
- Publication type:
- Article
Safety and Efficacy of Stereotactic Body Radiotherapy in Ultracentral Lung Tumors Using a Risk-optimized Fractionation Scheme.
- Published in:
- Clinical Lung Cancer, 2021, v. 22, n. 4, p. 332, doi. 10.1016/j.cllc.2020.11.003
- By:
- Publication type:
- Article
MET Amplification (MET/CEP7 Ratio ≥ 1.8) Is an Independent Poor Prognostic Marker in Patients With Treatment-naive Non–Small-cell Lung Cancer.
- Published in:
- Clinical Lung Cancer, 2021, v. 22, n. 4, p. e512, doi. 10.1016/j.cllc.2020.11.002
- By:
- Publication type:
- Article
Programmed Cell Death Ligand 1 Expression in Resected Non–Small Cell Lung Cancer.
- Published in:
- Clinical Lung Cancer, 2021, v. 22, n. 4, p. e555, doi. 10.1016/j.cllc.2020.09.018
- By:
- Publication type:
- Article
Deep and Durable Response to Nivolumab and Temozolomide in Small-Cell Lung Cancer Associated With an Early Decrease in Myeloid-Derived Suppressor Cells.
- Published in:
- Clinical Lung Cancer, 2021, v. 22, n. 4, p. e487, doi. 10.1016/j.cllc.2020.10.018
- By:
- Publication type:
- Article
Nomograms for Predicting Overall and Recurrence-free Survival From Pathologic Stage IA and IB Lung Cancer After Lobectomy.
- Published in:
- Clinical Lung Cancer, 2021, v. 22, n. 4, p. e574, doi. 10.1016/j.cllc.2020.10.009
- By:
- Publication type:
- Article
Nutritional Support in Lung Cancer Patients: The State of the Art.
- Published in:
- Clinical Lung Cancer, 2021, v. 22, n. 4, p. e584, doi. 10.1016/j.cllc.2020.10.008
- By:
- Publication type:
- Article
Brown-Séquard Syndrome in a Desmoplastic Malignant Mesothelioma Patient: A Rare Complication.
- Published in:
- Clinical Lung Cancer, 2021, v. 22, n. 4, p. e552, doi. 10.1016/j.cllc.2020.09.019
- By:
- Publication type:
- Article
Transformations First Into Squamous-Cell Carcinoma and Later Into Sarcomatoid Carcinoma After Acquired Resistance to Osimertinib in a Patient With EGFR-Mutant Lung Adenocarcinoma: Case Report.
- Published in:
- Clinical Lung Cancer, 2021, v. 22, n. 4, p. e536, doi. 10.1016/j.cllc.2020.06.026
- By:
- Publication type:
- Article
Mesothelioma Micronodular Metastasis Pattern Confirmed by Transbronchial Cryobiopsy: Case Report.
- Published in:
- Clinical Lung Cancer, 2021, v. 22, n. 4, p. e533, doi. 10.1016/j.cllc.2020.06.027
- By:
- Publication type:
- Article
Deterioration in Health-Related Quality of Life Diminishes Benefit of Lung Cancer Resection in Older Adults.
- Published in:
- Clinical Lung Cancer, 2021, v. 22, n. 4, p. e544, doi. 10.1016/j.cllc.2020.06.022
- By:
- Publication type:
- Article
Intracranial Response of ALK+ Non-Small-cell Lung Cancer to Second-line Dose-escalated Brigatinib After Alectinib Discontinuation Due to Drug-induced Hepatitis and Relapse After Whole Brain Radiotherapy Followed by Stereotactic Radiosurgery.
- Published in:
- Clinical Lung Cancer, 2021, v. 22, n. 4, p. e528, doi. 10.1016/j.cllc.2020.04.012
- By:
- Publication type:
- Article
Factors Affecting Long-Term Survival in Locally Advanced NSCLC Patients With Pathologic Complete Response After Induction Therapy Followed by Surgical Resection.
- Published in:
- Clinical Lung Cancer, 2021, v. 22, n. 4, p. e542, doi. 10.1016/j.cllc.2020.06.023
- By:
- Publication type:
- Article